Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sphere of biopharmaceuticals, giving promising improvements across various healthcare and industrial programs. With its structural similarity to In a natural way derived human serum albumin, OsrHSA presents a safer, far more trusted option for therapeutic use, specifica